BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharf R, Sarhan M, Dileone RJ. Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell. Biol Psychiatry 2008;64:175-83. [PMID: 18423425 DOI: 10.1016/j.biopsych.2008.03.006] [Cited by in Crossref: 105] [Cited by in F6Publishing: 99] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Mousavi Y, Azizi H, Mirnajafi-zadeh J, Javan M, Semnanian S. Blockade of orexin type-1 receptors in locus coeruleus nucleus attenuates the development of morphine dependency in rats. Neuroscience Letters 2014;578:90-4. [DOI: 10.1016/j.neulet.2014.06.038] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
2 Malherbe P, Borroni E, Gobbi L, Knust H, Nettekoven M, Pinard E, Roche O, Rogers-Evans M, Wettstein JG, Moreau JL. Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor. Br J Pharmacol 2009;156:1326-41. [PMID: 19751316 DOI: 10.1111/j.1476-5381.2009.00127.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 5.2] [Reference Citation Analysis]
3 Kalló I, Omrani A, Meye FJ, de Jong H, Liposits Z, Adan RAH. Characterization of orexin input to dopamine neurons of the ventral tegmental area projecting to the medial prefrontal cortex and shell of nucleus accumbens. Brain Struct Funct 2022. [PMID: 35029758 DOI: 10.1007/s00429-021-02449-8] [Reference Citation Analysis]
4 Leinninger GM. Lateral thinking about leptin: a review of leptin action via the lateral hypothalamus. Physiol Behav 2011;104:572-81. [PMID: 21550356 DOI: 10.1016/j.physbeh.2011.04.060] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
5 Wheeler DS, Wan S, Miller A, Angeli N, Adileh B, Hu W, Holland PC. Role of lateral hypothalamus in two aspects of attention in associative learning. Eur J Neurosci 2014;40:2359-77. [PMID: 24750426 DOI: 10.1111/ejn.12592] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
6 Baimel C, Bartlett SE, Chiou LC, Lawrence AJ, Muschamp JW, Patkar O, Tung LW, Borgland SL. Orexin/hypocretin role in reward: implications for opioid and other addictions. Br J Pharmacol 2015;172:334-48. [PMID: 24641197 DOI: 10.1111/bph.12639] [Cited by in Crossref: 97] [Cited by in F6Publishing: 92] [Article Influence: 12.1] [Reference Citation Analysis]
7 Dunn KE, Huhn AS, Bergeria CL, Gipson CD, Weerts EM. Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence. J Pharmacol Exp Ther 2019;371:422-52. [PMID: 31391211 DOI: 10.1124/jpet.119.258004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
8 Hooshmand B, Azizi H, Javan M, Semnanian S. Intra-LC microinjection of orexin type-1 receptor antagonist SB-334867 attenuates the expression of glutamate-induced opiate withdrawal like signs during the active phase in rats. Neuroscience Letters 2017;636:276-81. [DOI: 10.1016/j.neulet.2016.10.051] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
9 Ranjbar-slamloo Y, Azizi H, Fathollahi Y, Semnanian S. Orexin receptor type-1 antagonist SB-334867 inhibits the development of morphine analgesic tolerance in rats. Peptides 2012;35:56-9. [DOI: 10.1016/j.peptides.2012.02.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
10 Mahler SV, Smith RJ, Moorman DE, Sartor GC, Aston-Jones G. Multiple roles for orexin/hypocretin in addiction. Prog Brain Res 2012;198:79-121. [PMID: 22813971 DOI: 10.1016/B978-0-444-59489-1.00007-0] [Cited by in Crossref: 140] [Cited by in F6Publishing: 76] [Article Influence: 14.0] [Reference Citation Analysis]
11 Sharf R, Guarnieri DJ, Taylor JR, DiLeone RJ. Orexin mediates morphine place preference, but not morphine-induced hyperactivity or sensitization. Brain Res 2010;1317:24-32. [PMID: 20034477 DOI: 10.1016/j.brainres.2009.12.035] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 5.3] [Reference Citation Analysis]
12 Rezaei Z, Kourosh-arami M, Azizi H, Semnanian S. Orexin type-1 receptor inhibition in the rat lateral paragigantocellularis nucleus attenuates development of morphine dependence. Neuroscience Letters 2020;724:134875. [DOI: 10.1016/j.neulet.2020.134875] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
13 Fartootzadeh R, Azizi F, Alaei H, Reisi P. Orexin type-2 receptor blockade prevents the nicotine-induced excitation of nucleus accumbens core neurons in rats: An electrophysiological perspective. Pharmacol Rep 2019;71:361-6. [PMID: 30831442 DOI: 10.1016/j.pharep.2018.12.013] [Reference Citation Analysis]
14 Kenny PJ. Tobacco dependence, the insular cortex and the hypocretin connection. Pharmacol Biochem Behav 2011;97:700-7. [PMID: 20816891 DOI: 10.1016/j.pbb.2010.08.015] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
15 Ahmadi-soleimani SM, Ghaemi-jandabi M, Azizi H, Semnanian S. Orexin type 1 receptor antagonism in Lateral Paragigantocellularis nucleus attenuates naloxone precipitated morphine withdrawal symptoms in rats. Neuroscience Letters 2014;558:62-6. [DOI: 10.1016/j.neulet.2013.10.064] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
16 Łupina M, Tarnowski M, Baranowska-Bosiacka I, Talarek S, Listos P, Kotlińska J, Gutowska I, Listos J. SB-334867 (an Orexin-1 Receptor Antagonist) Effects on Morphine-Induced Sensitization in Mice-a View on Receptor Mechanisms. Mol Neurobiol 2018;55:8473-85. [PMID: 29557083 DOI: 10.1007/s12035-018-0993-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
17 Radke AK, Holtz NA, Gewirtz JC, Carroll ME. Reduced emotional signs of opiate withdrawal in rats selectively bred for low (LoS) versus high (HiS) saccharin intake. Psychopharmacology (Berl) 2013;227:117-26. [PMID: 23254375 DOI: 10.1007/s00213-012-2945-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
18 Baidoo N, Leri F. Extended amygdala, conditioned withdrawal and memory consolidation. Prog Neuropsychopharmacol Biol Psychiatry 2022;113:110435. [PMID: 34509531 DOI: 10.1016/j.pnpbp.2021.110435] [Reference Citation Analysis]
19 Laorden ML, Ferenczi S, Pintér-Kübler B, González-Martín LL, Lasheras MC, Kovács KJ, Milanés MV, Núñez C. Hypothalamic orexin--a neurons are involved in the response of the brain stress system to morphine withdrawal. PLoS One 2012;7:e36871. [PMID: 22590628 DOI: 10.1371/journal.pone.0036871] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
20 Wu X, Zhang JT, Liu J, Yang S, Chen T, Chen JG, Wang F. Calcitonin gene-related peptide erases the fear memory and facilitates long-term potentiation in the central nucleus of the amygdala in rats. J Neurochem 2015;135:787-98. [PMID: 26179152 DOI: 10.1111/jnc.13246] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
21 Aghajani N, Pourhamzeh M, Azizi H, Semnanian S. Central blockade of orexin type 1 receptors reduces naloxone induced activation of locus coeruleus neurons in morphine dependent rats. Neurosci Lett 2021;755:135909. [PMID: 33892002 DOI: 10.1016/j.neulet.2021.135909] [Reference Citation Analysis]
22 Graebner AK, Iyer M, Carter ME. Understanding how discrete populations of hypothalamic neurons orchestrate complicated behavioral states. Front Syst Neurosci 2015;9:111. [PMID: 26300745 DOI: 10.3389/fnsys.2015.00111] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
23 Cason AM, Smith RJ, Tahsili-Fahadan P, Moorman DE, Sartor GC, Aston-Jones G. Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity. Physiol Behav 2010;100:419-28. [PMID: 20338186 DOI: 10.1016/j.physbeh.2010.03.009] [Cited by in Crossref: 155] [Cited by in F6Publishing: 150] [Article Influence: 12.9] [Reference Citation Analysis]
24 Huang M, Chen C, Chen L, Chang H, Chen C, Lin S, Xu K. Chronic ketamine abuse is associated with orexin-A reduction and ACTH elevation. Psychopharmacology 2020;237:45-53. [DOI: 10.1007/s00213-019-05342-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
25 Boutrel B, Cannella N, de Lecea L. The role of hypocretin in driving arousal and goal-oriented behaviors. Brain Res 2010;1314:103-11. [PMID: 19948148 DOI: 10.1016/j.brainres.2009.11.054] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 6.5] [Reference Citation Analysis]
26 Odegaard KE, Schaal VL, Clark AR, Koul S, Gowen A, Sankarasubramani J, Xiao P, Guda C, Lisco SJ, Yelamanchili SV, Pendyala G. Characterization of the intergenerational impact of in utero and postnatal oxycodone exposure. Transl Psychiatry 2020;10:329. [PMID: 32968044 DOI: 10.1038/s41398-020-01012-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Azhdari-zarmehri H, Reisi Z, Vaziri A, Haghparast A, Shaigani P, Haghparast A. Involvement of orexin-2 receptors in the ventral tegmental area and nucleus accumbens in the antinociception induced by the lateral hypothalamus stimulation in rats. Peptides 2013;47:94-8. [DOI: 10.1016/j.peptides.2013.07.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
28 Koob GF. Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development. Pharmacol Rev 2021;73:163-201. [PMID: 33318153 DOI: 10.1124/pharmrev.120.000083] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
29 Sil’kis IG. Possible Mechanisms for the Effects of Orexin on Hippocampal Functioning and Spatial Learning (analytical review). Neurosci Behav Physi 2013;43:1049-57. [DOI: 10.1007/s11055-013-9849-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
30 Khoo SY, Brown RM. Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA? CNS Drugs 2014;28:713-30. [PMID: 24942635 DOI: 10.1007/s40263-014-0179-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
31 Mahoney CE, Cogswell A, Koralnik IJ, Scammell TE. The neurobiological basis of narcolepsy. Nat Rev Neurosci 2019;20:83-93. [PMID: 30546103 DOI: 10.1038/s41583-018-0097-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 18.7] [Reference Citation Analysis]
32 Lawrence AJ. Regulation of alcohol-seeking by orexin (hypocretin) neurons. Brain Res 2010;1314:124-9. [PMID: 19646424 DOI: 10.1016/j.brainres.2009.07.072] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
33 Smith RJ, Aston-Jones G. Orexin / hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking. Eur J Neurosci 2012;35:798-804. [PMID: 22356621 DOI: 10.1111/j.1460-9568.2012.08013.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 7.4] [Reference Citation Analysis]
34 Han Y, Yuan K, Zheng Y, Lu L. Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders. Neurosci Bull 2020;36:432-48. [PMID: 31782044 DOI: 10.1007/s12264-019-00447-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
35 Thannickal TC, John J, Shan L, Swaab DF, Wu MF, Ramanathan L, McGregor R, Chew KT, Cornford M, Yamanaka A, Inutsuka A, Fronczek R, Lammers GJ, Worley PF, Siegel JM. Opiates increase the number of hypocretin-producing cells in human and mouse brain and reverse cataplexy in a mouse model of narcolepsy. Sci Transl Med 2018;10:eaao4953. [PMID: 29950444 DOI: 10.1126/scitranslmed.aao4953] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 12.3] [Reference Citation Analysis]
36 Voorhees CM, Cunningham CL. Involvement of the orexin/hypocretin system in ethanol conditioned place preference. Psychopharmacology (Berl) 2011;214:805-18. [PMID: 21107540 DOI: 10.1007/s00213-010-2082-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
37 Ahmadi-soleimani SM, Azizi H, Gompf HS, Semnanian S. Role of orexin type-1 receptors in paragiganto-coerulear modulation of opioid withdrawal and tolerance: A site specific focus. Neuropharmacology 2017;126:25-37. [DOI: 10.1016/j.neuropharm.2017.08.024] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
38 Azizi H, Mirnajafi-zadeh J, Rohampour K, Semnanian S. Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats. Neuroscience Letters 2010;482:255-9. [DOI: 10.1016/j.neulet.2010.07.050] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
39 Sadeghzadeh F, Namvar P, Naghavi FS, Haghparast A. Differential effects of intra-accumbal orexin-1 and -2 receptor antagonists on the expression and extinction of morphine-induced conditioned place preference in rats. Pharmacology Biochemistry and Behavior 2016;142:8-14. [DOI: 10.1016/j.pbb.2015.12.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
40 Christopher JA. Orexin receptor antagonists. Pharm Pat Anal 2012;1:329-46. [PMID: 24236845 DOI: 10.4155/ppa.12.27] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
41 Jupp B, Lawrence AJ. New horizons for therapeutics in drug and alcohol abuse. Pharmacology & Therapeutics 2010;125:138-68. [DOI: 10.1016/j.pharmthera.2009.11.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
42 Amodeo LR, Wills DN, Sanchez-Alavez M, Nguyen W, Conti B, Ehlers CL. Intermittent voluntary ethanol consumption combined with ethanol vapor exposure during adolescence increases drinking and alters other behaviors in adulthood in female and male rats. Alcohol 2018;73:57-66. [PMID: 30293056 DOI: 10.1016/j.alcohol.2018.04.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
43 Aston-Jones G, Smith RJ, Sartor GC, Moorman DE, Massi L, Tahsili-Fahadan P, Richardson KA. Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction. Brain Res 2010;1314:74-90. [PMID: 19815001 DOI: 10.1016/j.brainres.2009.09.106] [Cited by in Crossref: 238] [Cited by in F6Publishing: 242] [Article Influence: 18.3] [Reference Citation Analysis]
44 McGinn MA, Pantazis CB, Tunstall BJ, Marchette RCN, Carlson ER, Said N, Koob GF, Vendruscolo LF. Drug addiction co-morbidity with alcohol: Neurobiological insights. Int Rev Neurobiol 2021;157:409-72. [PMID: 33648675 DOI: 10.1016/bs.irn.2020.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Davoudi M, Azizi H, Mirnajafi-zadeh J, Semnanian S. Decrease of inhibitory synaptic currents of locus coeruleus neurons via orexin type 1 receptors in the context of naloxone-induced morphine withdrawal. J Physiol Sci 2019;69:281-93. [DOI: 10.1007/s12576-018-0645-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
46 Boutrel B, Steiner N, Halfon O. The hypocretins and the reward function: what have we learned so far? Front Behav Neurosci 2013;7:59. [PMID: 23781178 DOI: 10.3389/fnbeh.2013.00059] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
47 Mahmoudi D, Assar N, Mousavi Z, Katebi SN, Azizi P, Haghparast A. The orexin receptors in the ventral tegmental area are involved in the development of sensitization to expression of morphine-induced preference in rats. Behav Pharmacol 2020;31:759-67. [PMID: 32925229 DOI: 10.1097/FBP.0000000000000587] [Reference Citation Analysis]
48 Forray A, Sofuoglu M. Future pharmacological treatments for substance use disorders. Br J Clin Pharmacol 2014;77:382-400. [PMID: 23039267 DOI: 10.1111/j.1365-2125.2012.04474.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
49 Kourosh-Arami M, Joghataei MT, Komaki A, Gholami M, Najafi Z, Lavaie M. Persistent effects of the orexin-1 receptor antagonist SB-334867 on naloxone precipitated morphine withdrawal symptoms and nociceptive behaviors in morphine dependent rats. Int J Neurosci 2020;:1-10. [PMID: 32746675 DOI: 10.1080/00207454.2020.1802266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Riahi E, Khodagholi F, Haghparast A. Role of dorsal hippocampal orexin-1 receptors in associating morphine reward with contextual stimuli. Behav Pharmacol 2013;24:237-48. [PMID: 23787292 DOI: 10.1097/FBP.0b013e3283635ee9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 2.9] [Reference Citation Analysis]
51 von der Goltz C, Koopmann A, Dinter C, Richter A, Grosshans M, Fink T, Wiedemann K, Kiefer F. Involvement of orexin in the regulation of stress, depression and reward in alcohol dependence. Horm Behav 2011;60:644-50. [PMID: 21945150 DOI: 10.1016/j.yhbeh.2011.08.017] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
52 Erami E, Azhdari-zarmehri H, Rahmani A, Ghasemi-dashkhasan E, Semnanian S, Haghparast A. Blockade of orexin receptor 1 attenuates the development of morphine tolerance and physical dependence in rats. Pharmacology Biochemistry and Behavior 2012;103:212-9. [DOI: 10.1016/j.pbb.2012.08.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
53 Chen Q, de Lecea L, Hu Z, Gao D. The hypocretin/orexin system: an increasingly important role in neuropsychiatry. Med Res Rev 2015;35:152-97. [PMID: 25044006 DOI: 10.1002/med.21326] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 5.5] [Reference Citation Analysis]
54 Walker LC, Lawrence AJ. The Role of Orexins/Hypocretins in Alcohol Use and Abuse. In: Lawrence AJ, de Lecea L, editors. Behavioral Neuroscience of Orexin/Hypocretin. Cham: Springer International Publishing; 2017. pp. 221-46. [DOI: 10.1007/7854_2016_55] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
55 Upadhya MA, Nakhate KT, Kokare DM, Singh U, Singru PS, Subhedar NK. CART peptide in the nucleus accumbens shell acts downstream to dopamine and mediates the reward and reinforcement actions of morphine. Neuropharmacology 2012;62:1823-33. [DOI: 10.1016/j.neuropharm.2011.12.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
56 Plaza-Zabala A, Maldonado R, Berrendero F. The hypocretin/orexin system: implications for drug reward and relapse. Mol Neurobiol 2012;45:424-39. [PMID: 22430644 DOI: 10.1007/s12035-012-8255-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
57 Davoudi M, Azizi H, Mirnajafi-zadeh J, Semnanian S. The blockade of GABAA receptors attenuates the inhibitory effect of orexin type 1 receptors antagonist on morphine withdrawal syndrome in rats. Neuroscience Letters 2016;617:201-6. [DOI: 10.1016/j.neulet.2016.02.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
58 Bodnar RJ. Endogenous opiates and behavior: 2008. Peptides 2009;30:2432-79. [PMID: 19793543 DOI: 10.1016/j.peptides.2009.09.027] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
59 Hooshmandi M, Hosseinmardi N, Janahmadi M, Khakpai F, Rohampour K, Doostmohammadi J. Antagonism of orexin type-1 receptors (OX1Rs) attenuates naloxone-precipitated morphine withdrawal syndrome in rat dorsal hippocampus. Pharmacology Biochemistry and Behavior 2017;158:39-48. [DOI: 10.1016/j.pbb.2017.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
60 Plaza-Zabala A, Flores Á, Maldonado R, Berrendero F. Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal. Biol Psychiatry 2012;71:214-23. [PMID: 21831361 DOI: 10.1016/j.biopsych.2011.06.025] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 5.5] [Reference Citation Analysis]
61 Sharf R, Sarhan M, Brayton CE, Guarnieri DJ, Taylor JR, DiLeone RJ. Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement. Biol Psychiatry 2010;67:753-60. [PMID: 20189166 DOI: 10.1016/j.biopsych.2009.12.035] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 6.2] [Reference Citation Analysis]
62 Farahmandfar M, Kadivar M, Rastipisheh S. Blockade of dorsal hippocampal orexin-1 receptors impaired morphine-induced state-dependent learning. Neuropeptides 2016;60:13-9. [DOI: 10.1016/j.npep.2016.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
63 Sharf R, Sarhan M, Dileone RJ. Role of orexin/hypocretin in dependence and addiction. Brain Res 2010;1314:130-8. [PMID: 19699189 DOI: 10.1016/j.brainres.2009.08.028] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 5.6] [Reference Citation Analysis]
64 James MH, Mahler SV, Moorman DE, Aston-Jones G. A Decade of Orexin/Hypocretin and Addiction: Where Are We Now? Curr Top Behav Neurosci 2017;33:247-81. [PMID: 28012090 DOI: 10.1007/7854_2016_57] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 16.0] [Reference Citation Analysis]
65 Iyer M, Essner RA, Klingenberg B, Carter ME. Identification of discrete, intermingled hypocretin neuronal populations. J Comp Neurol 2018;526:2937-54. [PMID: 30019757 DOI: 10.1002/cne.24490] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
66 Simmons SJ, Gentile TA, Mo L, Tran FH, Ma S, Muschamp JW. Nicotinic receptor blockade decreases fos immunoreactivity within orexin/hypocretin-expressing neurons of nicotine-exposed rats. Behav Brain Res 2016;314:226-33. [PMID: 27491589 DOI: 10.1016/j.bbr.2016.07.053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
67 Rorabaugh JM, Stratford JM, Zahniser NR. A relationship between reduced nucleus accumbens shell and enhanced lateral hypothalamic orexin neuronal activation in long-term fructose bingeing behavior. PLoS One. 2014;9:e95019. [PMID: 24736531 DOI: 10.1371/journal.pone.0095019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
68 de Lecea L, Carter ME, Adamantidis A. Shining light on wakefulness and arousal. Biol Psychiatry 2012;71:1046-52. [PMID: 22440618 DOI: 10.1016/j.biopsych.2012.01.032] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
69 Shoblock JR, Welty N, Aluisio L, Fraser I, Motley ST, Morton K, Palmer J, Bonaventure P, Carruthers NI, Lovenberg TW, Boggs J, Galici R. Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement. Psychopharmacology 2011;215:191-203. [DOI: 10.1007/s00213-010-2127-x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 102] [Article Influence: 8.3] [Reference Citation Analysis]
70 Babaie F, Kourosh-Arami M, Farhadi M. Administration of Orexin-A into the Rat Thalamic Paraventricular Nucleus Enhances the Naloxone Induced Morphine Withdrawal. Drug Res (Stuttg) 2022;72:209-14. [PMID: 35385881 DOI: 10.1055/a-1744-5868] [Reference Citation Analysis]
71 Taslimi Z, Haghparast A, Hassanpour-ezatti M, Safari M. Chemical stimulation of the lateral hypothalamus induces conditioned place preference in rats: Involvement of OX1 and CB1 receptors in the ventral tegmental area. Behavioural Brain Research 2011;217:41-6. [DOI: 10.1016/j.bbr.2010.10.007] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 4.4] [Reference Citation Analysis]
72 Reading PJ. Update on narcolepsy. J Neurol 2019;266:1809-15. [DOI: 10.1007/s00415-019-09310-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
73 Fragale JE, James MH, Avila JA, Spaeth AM, Aurora RN, Langleben D, Aston-Jones G. The Insomnia-Addiction Positive Feedback Loop: Role of the Orexin System. Front Neurol Neurosci 2021;45:117-27. [PMID: 34052815 DOI: 10.1159/000514965] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Mori K, Kim J, Sasaki K. Electrophysiological effects of orexin-B and dopamine on rat nucleus accumbens shell neurons in vitro. Peptides 2011;32:246-52. [DOI: 10.1016/j.peptides.2010.10.023] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
75 Ghaemi-jandabi M, Azizi H, Ahmadi-soleimani SM, Semnanian S. Intracoerulear microinjection of orexin-A induces morphine withdrawal-like signs in rats. Brain Research Bulletin 2017;130:107-11. [DOI: 10.1016/j.brainresbull.2017.01.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
76 Li Y, Wang H, Qi K, Chen X, Li S, Sui N, Kirouac GJ. Orexins in the midline thalamus are involved in the expression of conditioned place aversion to morphine withdrawal. Physiol Behav 2011;102:42-50. [PMID: 20951152 DOI: 10.1016/j.physbeh.2010.10.006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
77 Li YJ, Zhong F, Yu P, Han JS, Cui CL, Wu LZ. Electroacupuncture treatment normalized sleep disturbance in morphine withdrawal rats. Evid Based Complement Alternat Med 2011;2011:361054. [PMID: 19734257 DOI: 10.1093/ecam/nep133] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
78 Thompson JL, Borgland SL. A role for hypocretin/orexin in motivation. Behav Brain Res 2011;217:446-53. [PMID: 20920531 DOI: 10.1016/j.bbr.2010.09.028] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 6.2] [Reference Citation Analysis]
79 Matzeu A, Zamora-Martinez ER, Martin-Fardon R. The paraventricular nucleus of the thalamus is recruited by both natural rewards and drugs of abuse: recent evidence of a pivotal role for orexin/hypocretin signaling in this thalamic nucleus in drug-seeking behavior. Front Behav Neurosci 2014;8:117. [PMID: 24765071 DOI: 10.3389/fnbeh.2014.00117] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
80 Brown RM, Khoo SY, Lawrence AJ. Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats. International Journal of Neuropsychopharmacology 2013;16:2067-79. [DOI: 10.1017/s1461145713000333] [Cited by in Crossref: 66] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
81 Zarrabian S, Riahi E, Karimi S, Razavi Y, Haghparast A. The potential role of the orexin reward system in future treatments for opioid drug abuse. Brain Research 2020;1731:146028. [DOI: 10.1016/j.brainres.2018.11.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
82 Yazdi F, Jahangirvand M, Pirasteh A, Moradi M, Haghparast A. Functional interaction between OX2 and CB1 receptors in the ventral tegmental area and the nucleus accumbens in response to place preference induced by chemical stimulation of the lateral hypothalamus. Pharmacology Biochemistry and Behavior 2015;139:39-46. [DOI: 10.1016/j.pbb.2015.10.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
83 Aston-Jones G, Smith RJ, Moorman DE, Richardson KA. Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology 2009;56 Suppl 1:112-21. [PMID: 18655797 DOI: 10.1016/j.neuropharm.2008.06.060] [Cited by in Crossref: 188] [Cited by in F6Publishing: 191] [Article Influence: 13.4] [Reference Citation Analysis]
84 Nagase H, Yamamoto N, Yata M, Ohrui S, Okada T, Saitoh T, Kutsumura N, Nagumo Y, Irukayama-tomobe Y, Ishikawa Y, Ogawa Y, Hirayama S, Kuroda D, Watanabe Y, Gouda H, Yanagisawa M. Design and Synthesis of Potent and Highly Selective Orexin 1 Receptor Antagonists with a Morphinan Skeleton and Their Pharmacologies. J Med Chem 2017;60:1018-40. [DOI: 10.1021/acs.jmedchem.6b01418] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
85 Hrabovszky E, Molnár CS, Borsay BÁ, Gergely P, Herczeg L, Liposits Z. Orexinergic input to dopaminergic neurons of the human ventral tegmental area. PLoS One 2013;8:e83029. [PMID: 24376626 DOI: 10.1371/journal.pone.0083029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
86 Haghparast A, Taslimi Z, Ramin M, Azizi P, Khodagholi F, Hassanpour-Ezatti M. Changes in phosphorylation of CREB, ERK, and c-fos induction in rat ventral tegmental area, hippocampus and prefrontal cortex after conditioned place preference induced by chemical stimulation of lateral hypothalamus. Behav Brain Res 2011;220:112-8. [PMID: 21295078 DOI: 10.1016/j.bbr.2011.01.045] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
87 España RA. Hypocretin/orexin involvement in reward and reinforcement. Vitam Horm 2012;89:185-208. [PMID: 22640614 DOI: 10.1016/B978-0-12-394623-2.00010-X] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
88 Pedrón VT, Taravini IR, Induni AS, Balerio GN. Baclofen did not modify sexually dimorphic c-Fos expression during morphine withdrawal syndrome. Synapse 2013;67:118-26. [DOI: 10.1002/syn.21620] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
89 Sadat-Shirazi MS, Soltani H, Nikpour N, Haghshenas M, Khalifeh S, Mokri A, Zarrindast MR. Alteration of orexin-A and PKCα in the postmortem brain of pure-opioid and multi-drug abusers. Neuropeptides 2020;83:102074. [PMID: 32741526 DOI: 10.1016/j.npep.2020.102074] [Reference Citation Analysis]
90 Calipari ES, España RA. Hypocretin/orexin regulation of dopamine signaling: implications for reward and reinforcement mechanisms. Front Behav Neurosci 2012;6:54. [PMID: 22933994 DOI: 10.3389/fnbeh.2012.00054] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
91 Ghazal P, Ciccocioppo R, Ubaldi M. Morphine dependence is associated with changes in neuropeptide S receptor expression and function in rat brain. Peptides 2013;46:6-12. [PMID: 23684726 DOI: 10.1016/j.peptides.2013.05.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
92 Nocjar C, Zhang J, Feng P, Panksepp J. The social defeat animal model of depression shows diminished levels of orexin in mesocortical regions of the dopamine system, and of dynorphin and orexin in the hypothalamus. Neuroscience 2012;218:138-53. [DOI: 10.1016/j.neuroscience.2012.05.033] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 6.6] [Reference Citation Analysis]
93 Ge J, Li G, Zhang H, Liu H, Qi C, Lin Y, Xue Q, Wu S, Liu Y, Wang W. An auto real-time jump tagging system for exploring stereotyped jumping behavior in mice. Biochem Biophys Res Commun 2021;579:122-8. [PMID: 34597995 DOI: 10.1016/j.bbrc.2021.09.064] [Reference Citation Analysis]
94 Yazdi-ravandi S, Razavi Y, Haghparast A, Goudarzvand M, Haghparast A. Orexin A induced antinociception in the ventral tegmental area involves D1 and D2 receptors in the nucleus accumbens. Pharmacology Biochemistry and Behavior 2014;126:1-6. [DOI: 10.1016/j.pbb.2014.08.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
95 Hao H, Luan X, Guo F, Sun X, Gong Y, Xu L. Lateral hypothalamic area orexin-A influence the firing activity of gastric distension-sensitive neurons and gastric motility in rats. Neuropeptides 2016;57:45-52. [PMID: 26919916 DOI: 10.1016/j.npep.2016.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
96 Dou L, Wang L, Li X, Liu Y, Li F, Wang L, Gao X, Huang W, Wang S, Gao C, Yu L, Liu D. Role of antithymocyte globulin in matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies. Medicine (Baltimore) 2021;100:e24725. [PMID: 33663084 DOI: 10.1097/MD.0000000000024725] [Reference Citation Analysis]
97 Taslimi Z, Arezoomandan R, Omranifard A, Ghalandari-Shamami M, Riahi E, Vafaei AA, Rashidy-Pour A, Haghparast A. Orexin A in the ventral tegmental area induces conditioned place preference in a dose-dependent manner: involvement of D1/D2 receptors in the nucleus accumbens. Peptides 2012;37:225-32. [PMID: 22885169 DOI: 10.1016/j.peptides.2012.07.023] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
98 Tabaeizadeh M, Motiei-langroudi R, Mirbaha H, Esmaeili B, Tahsili-fahadan P, Javadi-paydar M, Ghaffarpour M, Dehpour AR. The differential effects of OX1R and OX2R selective antagonists on morphine conditioned place preference in naïve versus morphine-dependent mice. Behavioural Brain Research 2013;237:41-8. [DOI: 10.1016/j.bbr.2012.09.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
99 Lebold TP, Bonaventure P, Shireman BT. Selective orexin receptor antagonists. Bioorg Med Chem Lett 2013;23:4761-9. [PMID: 23891187 DOI: 10.1016/j.bmcl.2013.06.057] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
100 Panhelainen AE, Korpi ER. Evidence for a role of inhibition of orexinergic neurons in the anxiolytic and sedative effects of diazepam: A c-Fos study. Pharmacol Biochem Behav 2012;101:115-24. [PMID: 22210490 DOI: 10.1016/j.pbb.2011.12.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
101 Burma NE, Kwok CH, Trang T. Therapies and mechanisms of opioid withdrawal. Pain Manag 2017;7:455-9. [PMID: 29125396 DOI: 10.2217/pmt-2017-0028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
102 Scammell TE, Winrow CJ. Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol 2011;51:243-66. [PMID: 21034217 DOI: 10.1146/annurev-pharmtox-010510-100528] [Cited by in Crossref: 202] [Cited by in F6Publishing: 194] [Article Influence: 18.4] [Reference Citation Analysis]
103 Fakhari M, Azizi H, Semnanian S. Central antagonism of orexin type-1 receptors attenuates the development of morphine dependence in rat locus coeruleus neurons. Neuroscience 2017;363:1-10. [DOI: 10.1016/j.neuroscience.2017.08.054] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]